Allergic Conjunctivitis
📧 Sign up to get email alerts when something new happens for Allergic Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model [Phase 3]
Phase 3 trial evaluating the efficacy and safety of AL-4943A ophthalmic solution for allergic conjunctivitis; results were posted in 2013.
-
FDA approval · 2013-04-04FDA Approved: CROMOLYN SODIUM — Original Application (Micro Labs Limited)
FDA approved Micro Labs Limited's original ANDA for cromolyn sodium.
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis [Phase 3]
A Phase 3 study comparing topical bromfenac ophthalmic solution to placebo in allergic conjunctivitis has completed, assessing efficacy and …
-
FDA approval · 2013-03-13FDA Approved: AZELASTINE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for azelastine hydrochloride from Apotex Corp., as indicated by the FDA's 'AP' submission status for…
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis [Phase 4]
This Phase 4 clinical trial update reports results from a study evaluating the efficacy of Maxidex and Patanol for allergic conjunctivitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-21Clinical Trial Update: A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis [Phase 4]
Phase 4 study evaluating the duration of LASTACAFT (alcaftadine) in acute allergic conjunctivitis was completed. The results were posted in …
-
FDA approval · 2013-02-12FDA Approved: FML — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's supplemental application for FML (fluorometholone), resulting in updated labeling for the ophthalmic corticosteroid.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients [Phase 2]
Phase 2 trial update evaluating pharmacodynamic parameters and tolerability of grass pollen subcutaneous immunotherapy in patients with alle…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis [Phase 2]
This clinical trial update summarizes a Phase 2 study assessing how quickly RX-10045 works and how long its effects last in allergic conjunc…
-
FDA approval · 2012-12-18FDA Approved: VISINE ALLERGY EYE RELIEF MULTI-ACTION — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Visine Allergy Eye Relief Multi-Action, a combination eye drop containing naphazoline hydrochlor…
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of a sublingual immunotherapy solution for birch pollen–induced allergic rhinoconj…
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms [Phase 4]
Phase 4 study assessed the effect of fluticasone furoate nasal spray on spring allergy-related eye symptoms (allergic conjunctivitis) with c…
-
CLINICAL_TRIALS trial_result · 2012-09-18Clinical Trial Update: A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis [Phase 4]
Phase 4 trial evaluating patient perception and quality of life with olopatadine 0.2% for allergic conjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of a grass pollen sublingual tablet in children and adolescents with rhinoconjunctivitis/…
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) [Phase 3]
Phase 3 trial results evaluate the efficacy and safety of a grass pollen sublingual tablet in adults with allergic rhinitis with conjunctivi…
-
CLINICAL_TRIALS trial_result · 2012-07-25Clinical Trial Update: Assessment of Alcon's Ocular Image Quantification System [Phase 4]
A Phase 4 clinical trial evaluating Alcon's Ocular Image Quantification System for allergic conjunctivitis has completed and results have be…
-
FDA approval · 2012-06-28FDA Approved: BEPOTASTINE BESILATE — Supplemental Application (Bausch & Lomb Americas Inc.)
The FDA approved a supplemental application for Bepotastine besilate (Bausch & Lomb Americas Inc.). The action updates the labeling on an al…
-
FDA approval · 2012-05-31FDA Approved: AZELASTINE HYDROCHLORIDE — Original Application (Sandoz Inc)
FDA approved the original application for azelastine hydrochloride, a generic product from Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis [Phase 4]
Phase 4 study evaluating patient perceptions and quality of life associated with using olopatadine 0.2% for allergic conjunctivitis; results…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Bepotastine Besilate Ophthalmic Solution for allergic conjunctivitis has completed with …
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis [Phase 2, Phase 3]
This clinical trial update reports results from Phase 2 and Phase 3 studies evaluating how quickly Bepotastine Besilate ophthalmic solution …
-
CLINICAL_TRIALS trial_result · 2012-03-21Clinical Trial Update: Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge [Phase 2]
Phase 2 randomized trial comparing Loteprednol Ophthalmic Base and Loteprednol Ophthalmic Suspension versus placebo in an allergen challenge…
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation [Phase 2]
Phase 2 trial evaluating the efficacy of coadministration of FOV1101-00 with Prednisolone Acetate in patients with mild ocular allergic infl…
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis [Phase 2]
A Phase 2 trial evaluating the efficacy of low- and high-dose cyclosporine with prednisolone acetate, compared to its components and vehicle…
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC) [Phase 2]
A single-center Phase 2 randomized trial evaluated the duration of action of brimonidine tartrate ophthalmic solution for ocular redness cau…